§ Mrs. SpelmanTo ask the Secretary of State for Health how much public money has been spent on the AD2000 study of the effectiveness of donepezil in each of the years
101W(a) 1998, (b) 1999, (c) 2000 and (d) 2001, broken down by (i) the amount spent by individual health authorities on the trial, (ii) the amount allocated to the trial from regional research and development budgets, (iii) the amount allocated from the national research and development extra treatment costs fund and (iv) other NHS costs incurred as a result of the trial. [154072]
§ Ms Stuart[holding answer 16 March 2001]: The information is not available in the format requested.
The Department has been sponsoring a trial on the long-term effectiveness of donepezi1 (ARICEPT). The table shows expenditure from the west midlands regional office of the national health service executive and the excess treatment costs budget for this trial.
£ West midlands regional office Excess treatment costs 1997–98 5,000 — 1998–99 122,412 — 1999–2000 245,870 — 2000–01 225,723 145,000 2001–02 224,973 1200,000 1Estimate